packages containing 30 capsules.
EURETICO 50: packages containing 30 tablets. EURETICO: packages containing 16 tablets.
Packages containing 30 tablets.
Packages containing 20 and 40 coated tablets.
Cholesterol lowering treatment - HMG-CoA reductase inhibitor.
Adjuvant to the diet to reduce the levels of C-total, C-LDL, ApoB, C-noHDL and TG, and increase C-HDL. Pharmacological action: selective and competitive inhibitor of HMG-CoA reductase.
Dosage and route of administration.
Administer as a single dose at any time of the day, with or without food. The dose range is 5 to 40 mg. Recommended initial dose: 10 mg/day.
Known hypersensitivity to any component of the product; active liver disease or unaccountable persistent elevations in serum transaminases; pregnancy and breastfeeding.
Warnings and Precautions.
Liver enzymes: it is advised to measure them before and 12 weeks after the initiation of therapy and in case of any increase in dose. Use with caution in patients who consume substantial quantities of alcohol and/or have a history of liver disease. Advise patients to report immediately any unexplained pain, tenderness o muscle weakness.
Generally, they are mild and transient. The most frequent ones are myalgia, constipation, asthenia, abdominal pain and nausea.
Container with 28 coated tablets.